Effect of a vaccine to prevent serogroup A N meningitidis epidemics in Africa.
作者信息
Meyer Sarah A, Novak Ryan T
机构信息
Meningitis and Vaccine Preventable Diseases Branch, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
Meningitis and Vaccine Preventable Diseases Branch, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
出版信息
Lancet Infect Dis. 2017 Aug;17(8):789-790. doi: 10.1016/S1473-3099(17)30300-6. Epub 2017 May 22.
Abstract
摘要
相似文献
1
Effect of a vaccine to prevent serogroup A N meningitidis epidemics in Africa.一种预防非洲A群脑膜炎奈瑟菌流行的疫苗的效果。
Lancet Infect Dis. 2017 Aug;17(8):789-790. doi: 10.1016/S1473-3099(17)30300-6. Epub 2017 May 22.
2
Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data.布基纳法索 A 群脑膜炎球菌结合疫苗接种：国家监测数据分析。
Lancet Infect Dis. 2012 Oct;12(10):757-64. doi: 10.1016/S1473-3099(12)70168-8. Epub 2012 Jul 18.
3
Eliminating Meningococcal Epidemics From the African Meningitis Belt: The Case for Advanced Prevention and Control Using Next-Generation Meningococcal Conjugate Vaccines.消除非洲脑膜炎带的脑膜炎球菌病流行：使用新一代脑膜炎球菌结合疫苗进行高级预防和控制的案例。
J Infect Dis. 2019 Oct 31;220(220 Suppl 4):S274-S278. doi: 10.1093/infdis/jiz297.
4
A vaccine to prevent epidemic meningitis in Africa.一种预防非洲流行性脑膜炎的疫苗。
Lancet Infect Dis. 2012 Oct;12(10):738-9. doi: 10.1016/S1473-3099(12)70182-2. Epub 2012 Jul 18.
5
Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.非洲出现 X 群脑膜炎球菌病：需要疫苗。
Vaccine. 2013 Jun 12;31(27):2852-61. doi: 10.1016/j.vaccine.2013.04.036. Epub 2013 Apr 24.
6
An evaluation of emerging vaccines for childhood meningococcal disease.新兴儿童脑膜炎球菌病疫苗评估。
BMC Public Health. 2011 Apr 13;11 Suppl 3(Suppl 3):S29. doi: 10.1186/1471-2458-11-S3-S29.
7
Emergence of epidemic Neisseria meningitidis serogroup C in Niger, 2015: an analysis of national surveillance data.2015年尼日尔流行性C群脑膜炎奈瑟菌的出现：国家监测数据分析
Lancet Infect Dis. 2016 Nov;16(11):1288-1294. doi: 10.1016/S1473-3099(16)30253-5. Epub 2016 Aug 23.
8
Impact of serogroup A meningococcal conjugate vaccine for Africa.非洲 A 群脑膜炎球菌结合疫苗的影响。
Hum Vaccin Immunother. 2018 May 4;14(5):1116-1117. doi: 10.1080/21645515.2017.1412022. Epub 2018 Jan 16.
9
Future Directions for Meningitis Surveillance and Vaccine Evaluation in the Meningitis Belt of Sub-Saharan Africa.撒哈拉以南非洲脑膜炎带的脑膜炎监测和疫苗评估的未来方向。
J Infect Dis. 2019 Oct 31;220(220 Suppl 4):S279-S285. doi: 10.1093/infdis/jiz421.
10
Meningococcal factor H binding proteins in epidemic strains from Africa: implications for vaccine development.脑膜炎奈瑟菌结合因子 H 的流行株在非洲：对疫苗开发的影响。
PLoS Negl Trop Dis. 2011 Sep;5(9):e1302. doi: 10.1371/journal.pntd.0001302. Epub 2011 Sep 6.
引用本文的文献
1
Improved sub-seasonal forecasts to support preparedness action for meningitis outbreak in Africa.改进亚季节预测以支持非洲脑膜炎疫情的防范行动。
Clim Serv. 2022 Dec;28:100326. doi: 10.1016/j.cliser.2022.100326.
2
Pediatric Bacterial Meningitis Surveillance in Nigeria From 2010 to 2016, Prior to and During the Phased Introduction of the 10-Valent Pneumococcal Conjugate Vaccine.尼日利亚儿科细菌性脑膜炎监测：2010 年至 2016 年，在 10 价肺炎球菌结合疫苗分阶段引入之前和期间。
Clin Infect Dis. 2019 Sep 5;69(Suppl 2):S81-S88. doi: 10.1093/cid/ciz474.
本文引用的文献
1
Impact of MenAfriVac in nine countries of the African meningitis belt, 2010-15: an analysis of surveillance data.《2010-2015 年非洲脑膜炎带九个国家 MenAfriVac 的影响：监测数据分析》
Lancet Infect Dis. 2017 Aug;17(8):867-872. doi: 10.1016/S1473-3099(17)30301-8. Epub 2017 May 22.
2
Emergence of epidemic Neisseria meningitidis serogroup C in Niger, 2015: an analysis of national surveillance data.2015年尼日尔流行性C群脑膜炎奈瑟菌的出现：国家监测数据分析
Lancet Infect Dis. 2016 Nov;16(11):1288-1294. doi: 10.1016/S1473-3099(16)30253-5. Epub 2016 Aug 23.
3
Invasive Meningococcal Meningitis Serogroup C Outbreak in Northwest Nigeria, 2015 - Third Consecutive Outbreak of a New Strain.2015年尼日利亚西北部侵袭性C群脑膜炎球菌性脑膜炎疫情——新菌株连续第三次引发疫情
PLoS Curr. 2016 Jul 7;8:ecurrents.outbreaks.06d10b6b4e690917d8b0a04268906143. doi: 10.1371/currents.outbreaks.06d10b6b4e690917d8b0a04268906143.
4
Meningococcal Meningitis Surveillance in the African Meningitis Belt, 2004-2013.2004 - 2013年非洲脑膜炎带的脑膜炎球菌性脑膜炎监测
Clin Infect Dis. 2015 Nov 15;61 Suppl 5(Suppl 5):S410-5. doi: 10.1093/cid/civ597.
5
Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected].A 群脑膜炎奈瑟球菌结合疫苗（PsA-TT）对乍得 A 群脑膜炎奈瑟球菌脑膜炎和带菌的影响：一项社区研究[已更正]。
Lancet. 2014 Jan 4;383(9911):40-47. doi: 10.1016/S0140-6736(13)61612-8. Epub 2013 Sep 12.
6
Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity.A 群脑膜炎球菌结合疫苗（MenAfriVac）对带菌和群体免疫的影响。
Clin Infect Dis. 2013 Feb;56(3):354-63. doi: 10.1093/cid/cis892. Epub 2012 Oct 19.
7
Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data.布基纳法索 A 群脑膜炎球菌结合疫苗接种：国家监测数据分析。
Lancet Infect Dis. 2012 Oct;12(10):757-64. doi: 10.1016/S1473-3099(12)70168-8. Epub 2012 Jul 18.
8
Meningococcal disease: clinical presentation and sequelae.脑膜炎球菌病：临床表现和后遗症。
Vaccine. 2012 May 30;30 Suppl 2:B3-9. doi: 10.1016/j.vaccine.2011.12.062.
9
Costs and impact of meningitis epidemics for the public health system in Burkina Faso.布基纳法索公共卫生系统中脑膜炎流行的成本和影响。
Vaccine. 2011 Jul 26;29(33):5474-80. doi: 10.1016/j.vaccine.2011.05.058. Epub 2011 Jun 12.
10
Emergence of epidemic Neisseria meningitidis serogroup X meningitis in Togo and Burkina Faso.出现了流行性奈瑟氏脑膜炎奈瑟菌 X 群脑膜炎在多哥和布基纳法索。
PLoS One. 2011;6(5):e19513. doi: 10.1371/journal.pone.0019513. Epub 2011 May 20.
Zotero 插件